<DOC>
	<DOCNO>NCT00723047</DOCNO>
	<brief_summary>This multicenter , randomize , control trial conduct Groupe d'Etude Thérapeutique de Affections Inflammatoires du tube Digestif ( GETAID ) evaluate efficacy safety injection fibrin glue perianal fistula tracts patient CD . The institutional Independent Ethics Committee Marseille , France Liège , Belgium approve protocol participate center . Recruitment take place 12 site ( 11 France 1 Belgium )</brief_summary>
	<brief_title>Fibrin Glue Perianal Fistulas Crohn 's Disease : Randomized Controlled Trial</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>least 18 year old CD confirm endoscopy histology . CDAI 250 less least one perianal fistula ( anus low rectum perineum , vulva vagina ) drain 2 month duration treatment antiTNF agent ciclosporin tacrolimus within last 3 month presence perianal abscess ( &gt; 1cm ) assess magnetic resonance imaging ( MRI ) endoanal ultrasonography perform within last month , presence anal rectal stenosis , surgery previous month ( except seton removal ) , previous fibrin glue injection , pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Patients</keyword>
	<keyword>CD complicate</keyword>
	<keyword>least</keyword>
	<keyword>One perianal fistula</keyword>
	<keyword>Draining</keyword>
	<keyword>2 month duration</keyword>
</DOC>